Genetic analysis reveals a robust and hierarchical recruitment of the LolA chaperone to the LolCDE lipoprotein transporter
Open accessPreprint — published as 10.1128/mbio.03039-23
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The outer membrane (OM) is an essential organelle of Gram-negative bacteria. Lipoproteins are key to building the OM, performing essential functions in several OM assembly machines. Lipoproteins mature in the inner membrane (IM) and are then trafficked to the OM. In Escherichia coli , the LolCDE transporter is needed to extract lipoproteins from the IM to begin trafficking. Lipoproteins are then transferred from LolCDE to the periplasmic chaperone LolA which ferries them to the OM for insertion by LolB. LolA recruitment by LolC is an essential trafficking step. Structural and biochemical studies suggested that two regions (termed Hook and Pad) within a periplasmic loop of LolC worked in tandem to recruit LolA, leading to a bipartite model for recruitment. Here, we genetically examine the LolC periplasmic loop in vivo using E. coli . Our findings challenge the bipartite interaction model. We show that while the Hook is essential for lipoprotein trafficking in vivo , lipoproteins are still efficiently trafficked when the Pad residues are inactivated. We show with AlphaFold2 multimer modeling that Hook:LolA interactions are likely universal among diverse Gram-negative bacteria. Conversely, Pad:LolA interactions vary across phyla. Our in vivo data redefine LolC:LolA recruitment into a hierarchical interaction model. We propose that the Hook is the major player in LolA recruitment, while the Pad plays an ancillary role that is important for efficiency but is ultimately dispensable. Our findings expand the understanding of a fundamental step in essential lipoprotein trafficking and have implications for efforts to develop new antibacterials that target LolCDE. IMPORTANCE: Resistance to current antibiotics is increasingly common. New antibiotics that target essential processes are needed to expand clinical options. For Gram-negative bacteria, their cell surface— the outer membrane (OM)—is an essential organelle and antibiotic barrier that is an attractive target for new antibacterials. Lipoproteins are key to building the OM. The LolCDE transporter is needed to supply the OM with lipoproteins and has been a focus of recent antibiotic discovery. In vitro evidence recently proposed a two-part interaction of LolC with LolA lipoprotein chaperone (which traffics lipoproteins to the OM) via “Hook” and “Pad” regions. We show that this model does not reflect lipoprotein trafficking in vivo . Only the Hook is essential for lipoprotein trafficking and is remarkably robust to mutational changes. The Pad is non-essential for lipoprotein trafficking but plays an ancillary role, contributing to trafficking efficiency. These insights inform ongoing efforts to drug LolCDE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Research works printed but not linked: 59
- 10.1146/annurev-micro-090816-093754 · DOI · Paper page
- 2022, Physical properties of the bacterial outer membrane, Nat Rev Microbiol, 20, 236, 10.1038/s41579-021-00638-0 · DOI · Paper page
- 2006, Probing the Barrier Function of the Outer Membrane with Chemical Conditionality, ACS Chem Biology, 1, 385, 10.1021/cb600128v · DOI · Paper page
- 10.1111/nyas.14921 · DOI
- 2022, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, The Lancet, 399, 629, 10.1016/S0140-6736(21)02724-0 · DOI · Paper page
- 2019, Countering Gram-Negative Antibiotic Resistance: Recent Progress in Disrupting the Outer Membrane with Novel Therapeutics. Antibiotics (Basel, Switzerland, 8, 163
- 10.1038/s41573-023-00791-6 · DOI
- 10.1038/nrmicro.2016.25 · DOI · Paper page
- 2022, Function of the Omp85 Superfamily of Outer Membrane Protein Assembly Factors and Polypeptide Transporters, Annu Rev Microbiol, 76, 259, 10.1146/annurev-micro-033021-023719 · DOI
- 2018, Lipoprotein Transport: Greasing the Machines of Outer Membrane Biogenesis, Bioessays, 40, 1700187, 10.1002/bies.201700187 · DOI
- 10.1093/femsre/fuu006 · DOI
- 2021, Lipoproteins in Gram-negative bacteria: new insights into their biogenesis, subcellular targeting and functional roles, Curr Opin Microbiol, 61, 25, 10.1016/j.mib.2021.02.003 · DOI
- 2019, Lipoproteins and Their Trafficking to the Outer Membrane, Ecosal Plus, 8, 67
- 10.1038/35008635 · DOI · Paper page
- 10.1128/JB.184.5.1417-1422.2002 · DOI
- 10.1111/j.1365-2958.2006.05378.x · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb07342.x · DOI · Paper page
- 10.1093/emboj/16.23.6947 · DOI · Paper page
- 10.1073/pnas.1702248114 · DOI · Paper page
- 10.1073/pnas.1906158116 · DOI · Paper page
- 10.1128/JB.02552-14 · DOI · Paper page
- 10.1128/JB.02352-14 · DOI
- 2018, A Novel Inhibitor of the LolCDE ABC Transporter Essential for Lipoprotein Trafficking in Gram-Negative Bacteria, Antimicrob Agents Chemother, 62, e02151
- 2021, Transport of lipopolysaccharides and phospholipids to the outer membrane, Curr Opin Microbiol, 60, 51, 10.1016/j.mib.2021.01.006 · DOI
- 10.1073/pnas.1806822115 · DOI · Paper page
- 10.1038/s41594-021-00573-x · DOI
- 10.1128/JB.02414-14 · DOI
- 10.1128/jb.179.9.2857-2862.1997 · DOI · Paper page
- 1969, Chemical Characterization, Spatial Distribution and Function of a Lipoprotein (Murein-Lipoprotein) of the E. coli Cell Wall. Eur J Biochem, 10, 426
- Asmar AT , Collet J-F . 2018. Lpp, the Braun lipoprotein, turns 50—major achievements and remaining issues. FEMS Microbiol Lett 365. · DOI · Paper page
- 10.1016/j.cell.2014.02.033 · DOI · Paper page
- 10.1073/pnas.1604100113 · DOI
- 2023, LptM promotes oxidative maturation of the lipopolysaccharide translocon by substrate binding mimicry, Nat Commun, 14, 6368, 10.1038/s41467-023-42007-w · DOI · Paper page
- 10.1126/science.1143993 · DOI
- 10.1073/pnas.0912872107 · DOI · Paper page
- 2018, Lipoprotein Signal Peptidase Inhibitors with Antibiotic Properties Identified through Design of a Robust In Vitro HT Platform, Cell Chem Biology, 25, 301, 10.1016/j.chembiol.2017.12.011 · DOI
- 2020, Optimization of globomycin analogs as novel gram-negative antibiotics, Bioorg Med Chem Lett, 30, 127419, 10.1016/j.bmcl.2020.127419 · DOI
- 2021, Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun’s Lipoprotein, J Bacteriol, 203, e00149
- 2022, Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Acinetobacter baumannii, Proc National Acad Sci, 119, e2123117119, 10.1073/pnas.2123117119 · DOI
- 10.1371/journal.pgen.1003834 · DOI · Paper page
- 10.1128/IAI.72.7.3987-4003.2004 · DOI
- 10.1128/IAI.73.2.1081-1096.2005 · DOI · Paper page
- 10.1128/IAI.01529-07 · DOI
- 10.1016/j.micpath.2009.09.002 · DOI
- 2020, Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase, mBio, 11, e02018
- 2022, Cryo-EM structures of LolCDE reveal the molecular mechanism of bacterial lipoprotein sorting in Escherichia coli, Plos Biol, 20, e3001823, 10.1371/journal.pbio.3001823 · DOI
- 2021, Mechanism of LolCDE as a molecular extruder of bacterial triacylated lipoproteins, Nat Commun, 12, 4687, 10.1038/s41467-021-24965-1 · DOI
- 10.1016/j.febslet.2008.05.022 · DOI
- 10.1128/JB.05013-11 · DOI
- 2023, Teasing apart the evolution of lipoprotein trafficking in gram-negative bacteria reveals a bifunctional LolA, Proc National Acad Sci, 120, e2218473120, 10.1073/pnas.2218473120 · DOI
- 10.1074/jbc.M113.539270 · DOI
- 2006, Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection, Mol Syst Biology, 2, 2006.0008-2006.0008
- 10.1073/pnas.120163297 · DOI · Paper page
- 10.1128/JB.180.23.6408-6411.1998 · doi:10.1128/jb.180.23.6408-6411.1998
- 10.1073/pnas.100127597 · DOI · Paper page
- 10.1111/mmi.13772 · DOI
- 10.1073/pnas.2018329118 · DOI
- 10.1073/pnas.0604744103 · DOI · Paper page
- 2022, SignalP 6.0 predicts all five types of signal peptides using protein language models, Nat Biotechnol, 40, 1023, 10.1038/s41587-021-01156-3 · DOI · Paper page
Metadata
- Authors
- Lehman, K. M., May, K. L., Marotta, J., & Grabowicz, M.
- Affiliations
- Emory University (US)
- Corresponding author
- May, Kerrie L.
- Grabowicz, Marcin
- Venue
- mBio
- Publisher
- openRxiv
- Published
- 2023-11-08
- Volume
- 15
- Issue
- 2
- Pages
- e0303923-e0303923
- ISSN
- 2150-7511 (ISSN-L)
- PMC
- PMC10865981
- OpenAlex
- W4390782181
- Cited by
- 5
- References
- 1
- Citations by year
- 2026: 3 · 2025: 2
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- mBio (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of General Medical Sciences (R35GM133509)
- National Institute of Allergy and Infectious Diseases (F31AI147589)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- outer membrane biogenesis, Gram-negative bacteria, antibiotic targets, drug target identification, bacterial outer membrane
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.